Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: AI stocks and energy plays getting noticed

Markets have had it rough, starting the month of August lower following one downer of a corporate earnings report after another. Wall Street has struggled since credit assessor Fitch downgraded the United States’ credit rating from gold-standard AAA to...

SolGold CEO Nick Mather on building a major gold and copper mining company

SolGold ( TSX: SOLG ) is a leading exploration company focussed on the discovery and definition of world-class copper-gold deposits. The company has a first mover advantage in Ecuador, a highly prospective yet under-explored section of the Andean Copper Belt, home of multipl...

A psychedelic renaissance

Fifty-three years after LSD was banned by the FDA, psychedelic drugs are making a comeback. Only instead of being the pills, mushrooms and acid tabs that helped college students to “turn on, tune in, drop out” Timothy Leary-style, today’...

Stockhouse Media Exclusive: The Diamond Report

Dean Taylor knows diamonds. In fact, the CEO of Diamcor Mining Inc. (DMI) ( TSX-V:DMI , OTC:DMIFF , Forum ) has been running DMI since 2007, and that's a long at the helm in the mining space. His company is an established, production-based diamond miner with propertie...

Leap Therapeutics Lunges Forward on $132M Licensing Deal and $27M Equity Raise

Shares of Leap Therapeutics jumped 60% after the company reported that it signed an exclusive option and license agreement for its immuno-oncology drug DKN-01 with BeiGene in the Asia Pacific region excluding Japan. The firm also secured an additional $27 million in equity fin...

Vir Biotech Shares Rise on Joint Research Efforts with the NIH to Combat Coronaviruses

Vir Biotechnology shares traded higher after the company reported that it has entered into a research collaboration with the National Institutes of Health Vaccine Research Center on antibodies against coronaviruses including SARS-CoV-2. Clinical-stage immuno...

BeiGene Shares Up 35% on Amgen's $2.7 Billion Investment and China Partnership

Shares of BeiGene Ltd. traded 35% higher today to a new a 52-week intraday high after announcing a commercialization agreement for of XGEVA (denosumab), KYPROLIS (carfilzomib), and BLINCYTO (blinatumomab) with Amgen Inc. in China. As part of the partnership, Amgen will invest ...

When the levee breaks

In George Steinbeck’s epic novel ‘The Grapes of Wrath’, a poor family of tenant farmers and thousands of other “Oakies” hitch up their wagons to make the trek to California in search of work and a better life. A savage dr...

Multi-billion dollar valuation set for dynaCERT Inc. (V.DYA), pieces falling into place

dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) this week announced it has received its European ABE (German for “permit of operation”) certification for the Company’s HydraGEN™ (HG) Carbon Emission Reduction Technology fo...

Marijuana Meltdown: The Next Chapter for Cannabis Investors

Since the Tulip Bubble, analysts and the media have focused on the cycle of Boom and Bust. They love catchphrases: the bull and the bear, the long and the short. A stock rises on the back of strong company results or a new sure-fire sector, and plummets when things ...
1 2 3 4